相似文献
1
Transient hyperthyroidism following L-asparaginase therapy for acute lymphoblastic leukemia.
Med J Malaysia. 2000 Dec;55(4):513-5.
2
L-asparaginase-induced posterior reversible encephalopathy syndrome during acute lymphoblastic leukemia treatment in children.
Neuropediatrics. 2008 Feb;39(1):46-50. doi: 10.1055/s-2008-1076740.
3
L-asparaginase induced intracranial haemorrhage in acute lymphoblastic leukemia.
Singapore Med J. 1998 Feb;39(2):76-8.
4
L-asparaginase-induced severe necrotizing pancreatitis successfully treated with percutaneous drainage.
Pediatr Blood Cancer. 2005 Jan;44(1):95-7. doi: 10.1002/pbc.20187.
5
Thrombosis associated with L-asparaginase therapy and low fibrinogen levels in adult acute lymphoblastic leukemia.
Am J Hematol. 2004 Dec;77(4):331-5. doi: 10.1002/ajh.20230.
6
Transient hyperammonemia due to L-asparaginase therapy in children with acute lymphoblastic leukemia or non-Hodgkin lymphoma.
Pediatr Hematol Oncol. 2011 Feb;28(1):3-9. doi: 10.3109/08880018.2010.484852. Epub 2010 Jul 8.
7
Thyroid function is not affected by second exposure to erwinia asparaginase for childhood acute lymphoblastic leukemia.
Haematologica. 1997 Jul-Aug;82(4):507-8.
8
Pancreatic pseudocyst complicating treatment of acute lymphoblastic leukemia.
Indian Pediatr. 2003 Jul;40(7):670-2.
9
Allogeneic bone marrow transplantation after L-asparaginase-induced pancreatitis in a patient with acute lymphoblastic leukemia.
Leuk Res. 2008 Dec;32(12):1944-6. doi: 10.1016/j.leukres.2008.04.013. Epub 2008 May 27.
10
Octreotide therapy in asparaginase-associated pancreatitis in childhood acute lymphoblastic leukemia.
Pediatr Blood Cancer. 2008 Dec;51(6):824-5. doi: 10.1002/pbc.21721.
Zotero 插件